Rubicon Research lists with 28% premium on the BSE
Rubicon Research has debuted at Rs 620.10 on the BSE, up by 135.10 points or 27.86% from its issue price of Rs 485.00.
The scrip is currently trading at Rs. 602.15, up by 117.15 points or 24.15% from its issue price.
It has touched a high and low of Rs. 620.10 and Rs. 590.00 respectively. So far 11.90 lakh shares were traded on the counter.
The offering, which was open for subscription between October 09, 2025 and October 13, 2025 was subscribed 109.35 times. The issue price was fixed at Rs 485.00 per share i.e. at upper end of price band of Rs 461-485 apiece.
Rubicon Research is a pharmaceutical formulations company, driven by innovation through focused research and development, with an increasing portfolio of speciality products and drug-device combination products targeting regulated markets and in particular the United States.
